In contrast to endothelial cells, much higher concentrations of ISL were required to inhibit the proliferation of breast cancer cell line MCF-7 and MDA-MB-231(Figure 1B), suggesting that ISL had greater specificity as an inhibitor for VEGF-induced endothelial cell proliferation. Here, VEGFA is linked to breast carcinoma.